Synovus Financial Corp.

Equities

SNV

US87161C5013

Banks

Market Closed - Nyse 04:00:01 2024-02-26 pm EST 5-day change 1st Jan Change
37.26 USD +0.46% Intraday chart for Synovus Financial Corp. +1.53% -1.04%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Transcript : Synovus Financial Corp. Presents at Bank of America Securities Financial Services Conference 2024, Feb-21-2024 03:20 PM
UBS Adjusts Synovus Financial Price Target to $44 From $42, Maintains Buy Rating MT
Keefe, Bruyette & Woods Adjusts Price Target on Synovus Financial to $46 From $45, Maintains Outperform Rating MT
Sector Update: Financial Stocks Edge Up Late Afternoon MT
Sector Update: Financial MT
Synovus Financial Shares Rise Following Q4 Results MT
Transcript : Synovus Financial Corp., Q4 2023 Earnings Call, Jan 18, 2024
Earnings Flash (SNV) SYNOVUS FINANCIAL Posts Q4 EPS $0.80, vs. Street Est of $0.94 MT
Synovus Financial Q4 Adjusted Earnings, Revenue Decline -- Shares Down After Hours MT
Tranche Update on Synovus Financial Corp.'s Equity Buyback Plan announced on January 18, 2023. CI
Synovus Financial Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Synovus Financial Corp. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
North American Morning Briefing : Central Bankers -2- DJ
RBC Capital Adjusts Price Target on Synovus Financial to $42 From $37, Maintains Outperform Rating MT
Evercore ISI Downgrades Synovus Financial to In Line From Outperform, Sets Price Target at $40 MT
Synovus Financial Corp.'s Equity Buyback announced on January 18, 2023, has expired with 0 shares, representing 0% for $0 million. CI
Stephens Initiates Synovus Financial at Equal-Weight Rating With $40 Price Target MT
Goldman Sachs Adjusts Price Target on Synovus Financial to $37 From $33, Maintains Neutral Rating MT
Truist Securities Raises Price Target on Synovus Financial to $46 From $38, Maintains Buy Rating MT
Synovus Financial Insider Sold Shares Worth $675,728, According to a Recent SEC Filing MT
RBC Raises Price Target on Synovus Financial to $37 From $34, Says 2024 Guidance Suggests Continued Momentum, Keeps Outperform Rating MT
Transcript : Synovus Financial Corp. Presents at Goldman Sachs 2023 US Financial Services Conference, Dec-06-2023 02:20 PM
Truist Adjusts Synovus Financial's Price Target to $38 From $31, Maintains Buy Rating MT
Synovus Announces Quarterly Common Stock Dividends, Payable on January 2, 2024 CI
Synovus Announces Early Tender Results in Connection with Previously Announced Tender Offer and Extends Early Tender Payment to Apply Through Expiration Time CI
Chart Synovus Financial Corp.
More charts
Synovus Financial Corp. is a financial services company. The Company provides commercial and consumer banking products and services, including private banking, treasury management, wealth management, mortgage services, premium finance, asset-based lending, structured lending, capital markets, and international banking to its clients. Its segments include Community Banking, Wholesale Banking, Consumer Banking, and Financial Management Services (FMS). The Commercial Banking services includes treasury management, asset management, capital markets services, institutional trust services and commercial, financial and real estate loans. Its Consumer Banking services include accepting customary types of demand and savings deposits accounts; mortgage, installment and other consumer loans; investment and brokerage services; automated banking services; automated fund transfers; Internet-based banking services; and bank credit and debit card services, including Visa and MasterCard services.
Sector
Banks
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
37.26 USD
Average target price
42.97 USD
Spread / Average Target
+15.32%
Consensus
  1. Stock
  2. Equities
  3. Stock Synovus Financial Corp. - Nyse
  4. News Synovus Financial Corp.
  5. Jones Lang LaSalle's Capital Markets Group Arranges $1.3 Billion Medical Office Loan Portfolio Sale
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities.
SIGN UP NOW